Phase I Study of Intravesical Recombinant Fowlpox - GM-CSF (rF-GM-CSF) and/or Recombinant Fowlpox-TRICOM (rF-TRICOM) in Patients With Bladder Carcinoma Scheduled for Cystectomy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccine (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 23 Dec 2014 Biomarkers information updated
- 01 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jan 2013 Status changed from discontinued to recruiting as reported by ClinicalTrials.gov.